the efficacy of stereocyt was evaluated in 25 patients , who were divided into three subgroups : 10 patients with refractory hodgkin 's disease and 7 with refractory non-hodgkin lymphoma ( nhl ) , while 8 patients received prednimustine as primary therapy for low-grade nhl .
C0079747
low-grade nhl
C0024305
nhl